Directors

Vinogopal Ramayah Chairman	Mr Ramayah is Chairman of Cereus Holdings Ltd and Medtech Global. Mr Ramayah was previously a corporate adviser, Executive Director and Non-Executive Director of several Australasian and international companies and a partner of an international law firm specialising in corporate commercial practice. He also established several medical technology and airline projects and managed their commercial expansion into Asia-Pacific and Europe. Mr Ramayah serves on the Board of Asia-NZ Foundation and holds a LLB (Hons) and LLM (London).
Russell Clarke Non-Executive Director	Mr Clarke joined Cereus Holdings soon after it was founded in 1991. He is also an Executive Director of MedTech Global Limited, an ASX-listed company since 2001. Russell’s banking and merchant finance background includes former roles as Chief Lending and Credit Manager for New Zealand’s largest finance company at the time, Company Secretary of Bancorp Holdings Ltd during its period as a New Zealand publicly listed merchant bank, and Executive Director of Bancorp Corporate Advisory. Russell is also currently a director of a number of private companies and a director of an unlisted public investment company.
Paul Dyson Non-Executive Director	Mr Dyson is an entrepreneur and consultant with over 25 years experience in international technology companies. He has worked in Australia (8 years); France (8 years); the UK (7 years) and NZ (3 years). He has been CEO of two successful start-up technology companies (one in the UK and the other in India/ Russia). Mr Dyson is the founder and owner of a medical device consulting business as well as a medical distribution business that operates in the Middle East. He is a trustee of the Northern Cochlear Implant Trust (NCIT), a not-for-profit organisation in NZ and Graduate member of the Australian Institute of Directors and holds a BSc and BE(Elec Hons) from the University of Sydney.
Ganesan Pillay Non-Executive Director	Mr Pillay has over 30 years experience in the finance industry. He is a venture partner with New Zealand based iGlobe Treasury Management Ltd. Previously Mr Pillay was an Executive Vice President of The Development Bank of Singapore Limited where he held responsibility for international operations, treasury, trade finance, corporate planning and human resources. He was Managing Director and CEO of The Insurance Corporation of Singapore Limited. Mr Pillay served as a member of the Executive Committee of the Institute of Foreign Bankers in Japan and President of the Life Insurance Association in Singapore and holds a BA (Hons) and MBA (Harvard).
Hugh McCormack Managing Director	Mr McCormack has over 25 years experience in technology management, operations management and management consulting in the international medical device industry. He has worked as a consultant with the management consultancy Invetech focusing primarily on marketing and corporate strategy in the high-tech and medical industry sectors. He was also a strategic planning consultant with National Mutual Life Association (now AXA Australia). He holds a BSc (Chem) (Hons) and MBA from the University of Melbourne.

Management Team

Hugh McCormack Chief Executive Officer	Mr McCormack has over 25 years experience in technology management, operations management, management consulting in the international medical device industry. He has worked as a consultant with the management consultancy Invetech focusing primarily on marketing and corporate strategy in the high-tech and medical industry sectors. He was also a strategic planning consultant with National Mutual Life Association (now AXA Australia). He holds a BSc (Chem) (Hons) and MBA from the University of Melbourne.
Stephen Phua Head of Business Development. International	Stephen spent more than 15 years in the pharmaceutical industry holding many senior appointments. He was the CEO of an ASX listed company Agenix, the President of IMS Health Asia Pacific, the Managing Director and VP of Clinical Operations of Covance Asia Pacific and was the Head of the Oncology Business in Asia in Rhone Poulenc Rorer prior to their merger to become Sanofi Aventis. He was also the Group General Manager of Parkway Hospital Group in Singapore. Stephen graduated from the University of Singapore as a medical doctor and has a post graduate fellowship in the Faculty of Pharmaceutical Medicine of the RCOP in UK. He has consulted with many large companies in Asia especially on entry strategies and launch of new products. Stephen was a member of the Business Angel Networks of Southeast Asia, and was on the board of Apex, a Taiwan-based clinical research organization that was subsequently acquired by Paraxel. He is also a member of the international advisory board of the Korea National Enterprise for Clinical Trials (KoNECT).
Craig Newton Head of Business Development. ANZ & Head of Marketing	Mr Newton is an internationally experienced Business & Marketing Executive in the Pharmaceutical and Biotech sectors, among both large companies and small start-ups in Australasia, Asia and Europe. He has held senior marketing and sales management positions with Serono Laboratories UK Ltd, CSL Limited and Avax Australia Pty Ltd. He has experience in a diverse range of therapeutic areas, including oncology, haematology, orthopaedics, fertility, immunology and cardiovascular disease. He holds a Bachelor of Applied Science and postgraduate qualifications in management and marketing.
Graeme Smith Head of Business Development. EMEA	Graeme is an internationally experienced Business & Sales Executive in the Medical Device sector covering markets in Australasia, Europe and USA. He has held senior marketing and sales management positions with Tenaxis Medical Inc, LMA Urology Suisse SA, MedicaPro Ltd, United States Surgical Corporation (Auto Suture Co UK Ltd), He has experience in the sales and marketing of devices with applications in diverse range of therapeutic areas, including cardiovascular, respiratory and general surgery. His expertise is market access and growth in EMEA and USA setting up and managing distribution networks and driving sales with physician end-users.
Jorgen Kloster Winther European Business Manager	Mr Winther is an experienced distribution manager having managed the North European distribution network for Datascope Corporation as well as operating his own distribution business, Marcom-Medical for over 10 years. He was the Chairman for the Medical Devices Association Kirumed (Surgical) in Denmark and held senior marketing and sales management positions within the pharmaceutical industry with Upjohn, Organon and Merck, Sharp & Dome. He holds a medical degree from the University of Copenhagen, a Bachelor of Marketing and speaks five languages
Chang Seok Goo Head of Business Development. Asia Pacific	Seok Goo has held many senior positions in his 30 years in the pharmaceutical and healthcare industry. He was the Area VP of Korea in IMS Health and Commercial Director of Wellcome Korea prior to their merger with GSK. In Handok which is a JV with Sanofi Aventis, he played a critical role in their business development driving many licensing and strategic alliances with international companies in Europe, Japan and the US. He has succesfully launched and licensed products in the OTC and ethical segments with experience in the GI, cardiovascular and metabolic therapeutic areas. He is a pharmacist and has a MBA from Korea University.
Judith Gilfillan Regulatory Affairs, Quality Assurance Manager	Ms Gilfillan has been the Regulatory Affairs / Quality Assurance Manager of Bio Nova since 2005. Prior to that she had more than 15 years experience in medical device research and development as well as clinical evaluation programmes with Bio Nova International Pty Ltd, Bio Nova Neo Technics Pty Ltd and Cordis Bio-Synthetics Inc., a subsidiary of Cordis Corporation. She has also been responsible for documenting the safety and efficacy of medical devices prior to approval for use in humans as required by Australian, Canadian and USA regulatory authorities and holds a Dip. Appl. Sc.
Robert O’Dea Operations Manager	Mr O’Dea has over 25 years experience in the pharmaceutical and medical devices industries at senior management level. He held senior operational and quality assurance roles at CSL Limited and was the Plant Manager for Sigma Pharmaceuticals Limited. He holds a Bachelor of Applied Science and post-graduate qualifications in Quality Management.
Kim McKellar Veterinarian, Sheep Program Manager	Mr McKeller has been engaged in large animal and farm animal veterinary practice in Australia and North America for over 30 years and has owned and managed livestock farms for over 25 years. He has been involved in the development and testing of medical therapies in animals and the development of Bio Nova’s production processes. He provides management services and veterinary expertise to the Australian thoroughbred racing industry. He holds a BVSc (Hons) from the University of Melbourne.